Page last updated: 2024-10-24

celecoxib and Cognitive Decline

celecoxib has been researched along with Cognitive Decline in 3 studies

Research Excerpts

ExcerptRelevanceReference
"Cognitive dysfunction is induced by intraperational injection of lipopolysaccharide (LPS) in mice."1.43Co-administration of 3-Acetyl-11-Keto-Beta-Boswellic Acid Potentiates the Protective Effect of Celecoxib in Lipopolysaccharide-Induced Cognitive Impairment in Mice: Possible Implication of Anti-inflammatory and Antiglutamatergic Pathways. ( El Sayed, NS; Sayed, AS, 2016)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, JW1
Guan, PP1
Ding, WY1
Wang, SL1
Huang, XS1
Wang, ZY1
Wang, P1
Mhillaj, E1
Morgese, MG1
Tucci, P1
Furiano, A1
Luongo, L1
Bove, M1
Maione, S1
Cuomo, V1
Schiavone, S1
Trabace, L1
Sayed, AS1
El Sayed, NS1

Other Studies

3 other studies available for celecoxib and Cognitive Decline

ArticleYear
Erythrocyte membrane-encapsulated celecoxib improves the cognitive decline of Alzheimer's disease by concurrently inducing neurogenesis and reducing apoptosis in APP/PS1 transgenic mice.
    Biomaterials, 2017, Volume: 145

    Topics: 14-3-3 Proteins; Adaptor Proteins, Signal Transducing; Alzheimer Disease; Amyloid beta-Peptides; Ani

2017
Celecoxib Prevents Cognitive Impairment and Neuroinflammation in Soluble Amyloid β-treated Rats.
    Neuroscience, 2018, 02-21, Volume: 372

    Topics: Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Astrocytes; Brain-Derived N

2018
Co-administration of 3-Acetyl-11-Keto-Beta-Boswellic Acid Potentiates the Protective Effect of Celecoxib in Lipopolysaccharide-Induced Cognitive Impairment in Mice: Possible Implication of Anti-inflammatory and Antiglutamatergic Pathways.
    Journal of molecular neuroscience : MN, 2016, Volume: 59, Issue:1

    Topics: Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents; Celecoxib; Cognitive Dysfunction; Cyclooxy

2016